UK Smoking Rates at Historic Low as E-Cigarette Use Increases

Dec.07.2022
UK Smoking Rates at Historic Low as E-Cigarette Use Increases
Smoking in the UK hit an all-time low in 2021, but more people are turning to e-cigarettes, according to data.

New data shows that the number of smokers in the UK reached a historic low last year, but more people are using e-cigarettes.


According to data from the UK's National Statistics Office, approximately 13.3% of people aged 18 or older smoked in 2021, which is lower than the 14.0% reported in 2020.


However, among people aged 16 and above, 7.7% of them reported using e-cigarettes, compared to 6.4% in 2020.


The first record from the UK National Statistics Office about smoking was in 2011, which found that 20.2% of people had smoked at some point.


The UK's National Statistics Office has stated that the latest data represents a "statistically significant" decrease.


Is vaping a risk-free choice? Should disposable e-cigarettes be banned? James Tucker, who works in data analysis for the UK's Office for National Statistics' social care and health department, suggests that the decrease in smokers may partly be due to more people turning to e-cigarettes.


He said, "This is the lowest current smoking rate since 2011, when we began documenting smoking rates through the annual Population Survey (APS).


According to the UK's National Statistics Office, electronic cigarettes and other vaping devices have played a "significant role" in reducing the number of smokers in the UK.


According to the report, the use of electronic cigarettes is highest among current smokers, at 25.3%, followed by former smokers at 15.0%. Only 1.5% of those who have never smoked reported using e-cigarettes.


However, it added that electronic cigarettes may not be the only factor contributing to the decline in smoking. (Translated from Chinese)


This may also be due to increased public awareness campaigns and the implementation of smoke-free policies in places such as bars and offices.


The government's tobacco control program aims to reduce smoking rates among adults in England to 12% or lower by the end of 2022.


According to the UK's National Statistics Office, Scotland currently has the highest proportion of smokers in the country for 2021 at 14.8%, while England has the lowest at 13.0%.


In other locations, Wales and Northern Ireland have reported respective current smoking rates of 14.1% and 13.8%.


By 2021, men are more likely to be current smokers in the UK with a smoking rate of 15.1% compared to women's rate of 11.5%.


Currently, the age group with the most smokers is 25 to 34 years old, accounting for 15.8%, while the lowest is people aged 65 and over, at 8%.


According to the UK's Office for National Statistics, those who are not qualified are currently more likely to smoke, at a rate of 28.2%, compared to those with a degree or equivalent educational qualifications, who have a smoking rate of 6.6%.


According to the NHS website, while electronic cigarettes are not without some risk, that risk is lower than that of traditional cigarettes. However, the long-term effects of using electronic cigarettes have yet to be fully understood.


Selling e-cigarettes to those under the age of 18 is illegal.


2FIRSTS will continue to report on this topic and provide updates on our mobile app, 2FIRSTSAPP. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
Logista France says tobacco consumption outside France’s official tobacconist network has become a large and structural market phenomenon, but official and industry estimates differ sharply. France’s TAFE study estimates that 17.7% of tobacco consumption escaped domestic taxation in 2023, with most of that volume attributed to cross-border purchasing rather than street sales. Some industry studies use broader off-channel definitions and put the figure above 50%. Meanwhile, French Customs seized 547.94 tonnes of tobacco in 2025, up 12%, showing continued pressure from illicit trade.
Sep.04
BAT CFO Dragos Constantinescu Takes Office, Returning After Seven Years and Former Asahi Europe Leadership Role
BAT CFO Dragos Constantinescu Takes Office, Returning After Seven Years and Former Asahi Europe Leadership Role
Dragos Constantinescu has officially taken up his role as Chief Financial Officer and Executive Director at British American Tobacco (BAT). He previously spent 16 years at BAT across finance and general management roles in Europe before joining Asahi in 2019 and becoming CEO of Asahi Europe & International in 2025. His return comes as BAT continues to advance its “A Better Tomorrow” transformation.
BAT
Sep.01
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09